Associate Professor of Medicine, Beth Israel Deaconess Medical Center
Gastroenterology
Dr. Adam S. Cheifetz, MD
|
|
Give Review
Adam S. Cheifetz, MD is an expert in the field of Gastroenterology. He studied medicine at Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University is ranked 18 in research and 49 in primary care medicine He received awards:"Boston Magazine", "Fellow (AGAF)", "Meaningful Use Stage 1 Certification", "Super Doctor", "Fellow (FACG)" and "Top Doctors". Adam Cheifetz is a published physician. He has 102 publications published. The most current publication "Utility of Emergency Department Use of Abdominal Pelvic Computed Tomography in the Management of Crohn's Disease." Adam Cheifetz accepts Medicare payments and is listed with Medicare.gov.
Publications
- Editorial on "HIGHER ADALIMUMAB DRUG LEVELS ARE ASSOCIATED WITH MUCOSAL HEALING IN PATIENTS WITH CROHN'S Disease".
- Poor Documentation of Inflammatory Bowel Disease Quality Measures in Academic, Community, and Private Practice.
- Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled ...
- It Is Time to Treat to Trough: Staying Ahead of the Curve in Biologic Testing.
- Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel Disease.
- Adherence to Rectal Mesalamine in Patients with Ulcerative Colitis.
- Systematic analysis of the quality of the scientific evidence and conflicts of interest in osteoarthritis of the hip and knee practice guidelines.
- Surgery for Ulcerative Colitis Is Associated with a High Rate of Readmissions at 30 Days.
- Reply to Use of CT Scan in Ulcerative Colitis Patients Presenting to the Emergency Department.
- Utility of CT in the Emergency Department in Patients with Ulcerative Colitis.
- In Vitro Fertilization in Women with Inflammatory Bowel Disease is as Successful as inWomen from the General Infertility Population.
- Biologic Concentration Testing in Inflammatory Bowel Disease.
- Immune-mediated Reactions to Anti-tumor Necrosis Factors in Inflammatory Bowel Disease.
- A rare case series of concomitant inflammatory bowel Disease, sporadic adenomas, and serrated polyposis syndrome.
- Ulcerative colitis: epidemiology, diagnosis, and management.
- In Vitro Fertilization Is Successful in Women With Ulcerative Colitis and Ileal Pouch Anal Anastomosis.
- JAMA patient page. Crohn Disease.
- Documented Compliance with Inflammatory Bowel Disease Quality Measures Is Poor.
- CD39 and CD161 Modulate Th17 Responses in Crohn's Disease.
- Proactive Therapeutic Concentration Monitoring of Infliximab May Improve Outcomes for Patients with Inflammatory Bowel Disease: Results from a Pilot Observational Study.
- Miscellaneous adverse events with biologic agents (excludes infection and malignancy).
- High self-efficacy predicts adherence to surveillance colonoscopy in inflammatory bowel Disease.
- Colonoscopy is appropriately utilized in most cases following a fair Bowel prep.
- In reply--Clinical practice guidelines: still miles to go...
- Attitudes to Mesalamine Questionnaire: A Novel Tool to Predict Mesalamine Nonadherence in Patients with IBD.
- Varicella zoster virus infection in patients with inflammatory bowel Disease.
- Vitamin D Levels in Adults with Crohn's Disease Are Responsive to Disease Activity and Treatment.
- The use of pharmacological prophylaxis against venous thromboembolism in hospitalised patients with severe active Ulcerative colitis.
- Barriers to mesalamine adherence in patients with inflammatory bowel Disease: a qualitative analysis.
- Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel Disease.
- Characteristics of Inflammatory Bowel Disease Serology in Patients With Indeterminate Colitis.
- The Holistic Effects of Cannabis in Crohn's Disease.
- The Burden of Inflammatory Bowel Disease: A Patient-reported Qualitative Analysis and Development of a Conceptual Model.
- An appraisal of the current state of gastroenterology practice guidelines.
- Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in interventional medicine subspecialty guidelines.
- The Role of Mucosal Healing in the Treatment of Patients With Inflammatory Bowel Disease.
- Lectin-reactive Anti-α-Gal in Patients with Crohn's Disease: Correlation with Clinical Phenotypes.
- Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in gastroenterology practice guidelines.
- Efficacy and Safety of Natalizumab in Crohn's Disease Patients Treated at 6 Boston Academic Hospitals.
- Hickam's Dictum in a Patient With Diarrhea.
- Histologic markers of inflammation in patients with Ulcerative colitis in clinical remission.
- Letter: inflammatory bowel Disease guidelines and conflicts of interest - authors' reply.
- Letter: international IBD practice guidelines -- authors' reply.
- Commentary: Irritable bowel syndrome and the CDAI - misleading activity by straw men; authors' reply.
- Prevalence and Lifetime Risk of Endoscopy-Related Complications Among Patients with Inflammatory Bowel Disease.
- Management of active Crohn Disease.
- Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines.
- The Crohn's Disease activity index (CDAI) is similarly elevated in patients with Crohn's Disease and in patients with irritable bowel syndrome.
- Predictors of endoscopic inflammation in patients with Ulcerative colitis in clinical remission.
- Evaluation of the small bowel in inflammatory bowel Disease.
- Factors that Affect Adherence to Surveillance Colonoscopy in Patients with Inflammatory Bowel Disease.
- A random urine test can identify patients at risk of mesalamine non-adherence: a prospective study.
- How physicians interpret research funding disclosures.
- Setting priorities for comparative effectiveness research in inflammatory bowel Disease: Results of an international provider survey, expert rand panel, and patient fo...
- Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis.
- CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel Disease.
- Comparative effectiveness research in inflammatory bowel Disease: prospects and challenges.
- Infusion reactions related to infliximab therapy are not usually associated with drug discontinuation.
- Mycobacterium marinum: An Increasingly Common Opportunistic Infection in Patients on Infliximab.
- Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor alpha agents for inflammatory bowel Disease.
- Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease.
- Varicella zoster virus infection in inflammatory bowel Disease.
- Screening for tuberculosis and Hepatitis B prior to the initiation of anti-tumor necrosis therapy.
- Doctor message can alter patients' behavior and attitudes regarding inflammatory bowel disease and colon Cancer.
- Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's Disease.
- Abdominal phlegmons in Crohn's disease: Outcomes following antitumor necrosis factor therapy.
- Varicella zoster meningoradiculitis in Crohn's Disease treated with 6-mercaptopurine.
- Capsule endoscopy for small-bowel evaluation in Crohn's Disease.
- Cyclosporine is safe and effective in patients with severe Ulcerative colitis.
- Vaccination in inflammatory bowel Disease.
- Infliximab decreases colectomy rates in moderate to severe Ulcerative colitis: Big news or big deal?
- Capsule endoscopy in suspected Crohn's Disease: "yield" does not equal "diagnosis".
- The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's Disease: one size does not fit all.
- Impact of concomitant immunomodulator use on long-term outcomes in patients receiving scheduled maintenance infliximab.
- Targeting TNF in postoperative recurrence of Crohn's Disease: can we extinguish the fire before it starts?
- The utility of capsule endoscopy in patients with suspected Crohn's Disease.
- How often is a diagnosis of ulcerative colitis changed to Crohn's Disease and vice versa?
- Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group.
- Reducing the torment of diarrhea: tormentil for active Ulcerative colitis.
- The risk of retention of the capsule endoscope in patients with known or suspected Crohn's Disease.
- Capsule endoscopy retention: is it a complication?
- Thyroid Cancer and Crohn's disease: association or coincidence?
- Infliximab: Use in Inflammatory Bowel Disease.
- You say goodbye and I say aloe.
- Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active Ulcerative colitis.
- Failure to induce oral tolerance in Crohn's and Ulcerative colitis patients: possible genetic risk.
- Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel Disease: a new series and a review of 120 cases from the literature.
- Cryptosporidiosis masquerading as a Crohn's flare.
- Impact of a patient-support program on mesalamine adherence in patients with Ulcerative colitis--a prospective study.
- Management of acute severe Ulcerative colitis.
- Interventions for prevention of post-operative recurrence of Crohn''s Disease.
- Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn''s Disease.
- Meta-analysis of the placebo response in Ulcerative colitis.
- Forecasting the recurrence of Ulcerative colitis: can U.C. the future?
- The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn''s Disease.
- Melanin-concentrating hormone as a mediator of Intestinal inflammation.
- Anti-tumour necrosis factor therapy for Ulcerative colitis: evidence to date.
- Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's Disease receiving infliximab.
- Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha.
- Evidence for a genetic defect in oral tolerance induction in inflammatory bowel Disease.
- Utility of Emergency Department Use of Abdominal Pelvic Computed Tomography in the Management of Crohn's Disease.
Schools
Joan Sanford I Weill Medical College Of Cornell University
Yale New Haven Hospital
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- Boston Magazine
- Fellow (AGAF)
- Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACG)
- Top Doctors
Education
-
Yale-New Haven Hospital -
Mount Sinai School of Medicine -
Weill Cornell Medical College of Cornell University
Hospital
-
Beth Israel Deaconess Medical Center
Drug Facts
| NPI NUMBER | 1811934417 | |
| NPPES Provider LastName | CHEIFETZ | |
| NPPES Provider FirstName | ADAM | |
| NPPES Provider ZIPCode | 022155400 | |
| NPPES Provider State | MA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 148.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811934417 |
| Last Name Of The Provider | CHEIFETZ |
| First Name Of The Provider | ADAM |
| View All |
Similar Doctors
|
|
Dr. Vijay Yajnik, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Salina S. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard M. Rothstein, MD |
|
|
Dr. Abraham L. Brass, MD |
|
|
Dr. Jennifer Y. Chen, MD |
|
|
Dr. Jennifer T. Higa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel C. Chung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily Rostholder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Cohen, MD |
|
|
Dr. Robert Burakoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bernard R. Aserkoff, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rakhi N. Kheraj, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacqueline L. Wolf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suma S. Magge, MD
This Doctor is OpenDoctor Recommended.
|